NORTHWEST BIOTHERAPEUTICS INC (NWBO): debt financing — NWBO enters $5M convertible note with Yorkville for Sawston facility

NORTHWEST BIOTHERAPEUTICS INC

Promissory note of $5M with YA II PN, Ltd. (Yorkville) for 12 months, no payments due until maturity.
Note carries 5% original issue discount, no interest, and convertible at a small discount to market price.
Monthly conversion limited to ~1/5 of note amount unless conversion price above $0.29.
Proceeds to fund construction/equipment for first Grade C manufacturing suite at Sawston, UK, plus operations.

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.9

NORTHWEST BIOTHERAPEUTICS INC incurred convertible notes of $5 million with YA II PN, Ltd. at no interest maturing 12 months.

Instrument: convertible notes
Principal: $5 million
Counterparty: YA II PN, Ltd.
Rate: no interest
Maturity: 12 months
Event: incurrence

Exact text from the filing

On November 14, 2025 the Company entered into a $5 million convertible Promissory Note financing (the “Note”) with YA II PN, Ltd., an investment fund managed by Yorkville Advisors Global, LP (“Yorkville”).

View on SEC.gov

312 debt financings filed in the last 30 days. Browse all debt financings →

NORTHWEST BIOTHERAPEUTICS INC filing history →

Source: SEC EDGAR

accession 0001104659-25-114627

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.